Court faces “extremely daunting” task in privilege dispute between Bio-Rad and FCPA whistleblower

The right of in-house lawyers to sue employers for whistleblower retaliation is at stake in a legal privilege tussle between medical device company Bio-Rad Laboratories and a former general counsel.

Unlock unlimited access to all Global Investigations Review content